IN8BIO Inc.

12/10/2024 | Press release | Distributed by Public on 12/10/2024 06:14

IN8bio Reports Continued Progression Free Survival in Phase 1 Investigator Sponsored Trial of INB 100 Allogeneic Gamma Delta T Cells for Leukemias at the 2024 American Society[...]